Found 470 articles for: "atopic dermatitis"
The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers
October 2023 | Volume 22 | Issue 10 | Original Article | 1027 | Copyright © October 2023
Background: Skin conditions are associated with psychological symptoms and may be particularly distressing for skin of color (SoC) individuals. SoC consumers' decisions to pursue derm...
Read MoreFULL SUPPLEMENT: Management of Atopic Dermatitis in People with Skin of Color: A Practical Algorithm
August 2023 | Volume 22 | Issue 8 | Department | SF386361s1 | Copyright © August 2023
Background: Variations in the epidemiology, clinical presentation, and disease course in skin of color (SOC) atopic dermatitis (AD) patients have been reported that may impact treatme...
Read MoreOff-Label Use of Baricitinib in Dermatology
August 2023 | Volume 22 | Issue 8 | Original Article | 795 | Copyright © August 2023
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib ...
Read MoreINDIVIDUAL ARTICLE: An Algorithm for the Management of Atopic Dermatitis in People With Skin of Color
August 2023 | Volume 22 | Issue 8 | Supplement Individual Articles | SF386361s3 | Copyright © August 2023
Background: Variations in the epidemiology, clinical presentation, and disease course in skin of color (SOC) atopic dermatitis (AD) patients have been reported that may impact tr...
Read MoreDermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
August 2023 | Volume 22 | Issue 8 | Original Article | 817 | Copyright © August 2023
Background: The contribution of psychological disorders to the burden of skin disease has been poorly explored in adolescent patients. The review aims to provide insights into the psychological, socia...
Read MoreDiagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians
August 2023 | Volume 22 | Issue 8 | Original Article | 742 | Copyright © August 2023
Pediatric psoriasis (PsO) and its associated comorbidities carry physical and psychosocial burdens in children and adolescents, which can negatively impact quality of life. However, features dist...
Read MorePsoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 773 | Copyright © August 2023
Background: Psoriasis is a chronic immune-mediated dermatologic disorder with multisystemic comorbidities, which is effectively treated with a range of prescription therapies. St...
Read MoreA Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
August 2023 | Volume 22 | Issue 8 | Original Article | 761 | Copyright © August 2023
Psoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque ...
Read MoreTapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 779 | Copyright © August 2023
Topical treatments remain the foundation of psoriasis management. Tapinarof (VTAMA®; Dermavant Sciences, Inc.) is a first-in-class, non-steroidal, topical, aryl hydrocarbon receptor (AhR) ago...
Read MoreRacial and Ethnic Variations in Skin Barrier Properties and Cultural Practices in Skin of Color Newborns, Infants, and Children
July 2023 | Volume 22 | Issue 7 | Original Article | 657 | Copyright © July 2023
Background: The skin of newborns and infants of all races/ethnicity is more susceptible to skin barrier disruption than adult skin. This consensus paper offers insights into pote...
Read MoreA Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo
July 2023 | Volume 22 | Issue 7 | Original Article | 664 | Copyright © July 2023
Background: This article describes the clinical trial, safety, and efficacy of ruxolitinib 1.5% cream or repigmentation in patients with vitiligo.Data Sources: A sys...
Read MoreModified Fitzpatrick Scale-Skin Color and Reactivity
July 2023 | Volume 22 | Issue 7 | Original Article | 641 | Copyright © July 2023
Background: There is growing interest in the development of a skin classification system that captures the world's diverse population. The Fitzpatrick skin classification scale i...
Read MoreDermatologist Practical Guide to Encouraging Photoprotection in Skin of Color Patients
July 2023 | Volume 22 | Issue 7 | Features | 701 | Copyright © July 2023
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
June 2023 | Volume 22 | Issue 6 | Original Article | 588 | Copyright © June 2023
Background: Precision medicine utilizes an individual’s genomics to improve diagnosis, prognosis, and therapy. The joint American Academy of Dermatology and National Psoria...
Read MoreCross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases
June 2023 | Volume 22 | Issue 6 | Original Article | 576 | Copyright © June 2023
Background: A growing body of evidence suggests that several inflammatory skin diseases (ISDs) are associated with systemic inflammation and cardiovascular disease (CVDs)....
Read MoreAllergens in Common Brands of Clobetasol
May 2023 | Volume 22 | Issue 5 | Original Article | 491 | Copyright © May 2023
Background: Allergic contact dermatitis (ACD) may occur secondary to topical corticosteroids. This may be due to topical corticosteroids containing potential allergens in their v...
Read MoreDo Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
April 2023 | Volume 22 | Issue 4 | Original Article | 344 | Copyright © April 2023
Background: Research examining associations between the clinician-reported validated Investigator Global Assessment for AD (vIGA-AD) and patient-reported disease burden is sparse...
Read MoreAlgorithm to Improve Patient Comfort and Treat Diabetes Mellitus-Related Xerosis
April 2023 | Volume 22 | Issue 4 | Original Article | 356 | Copyright © April 2023
Background: Diabetes mellitus (DM)-related cutaneous disorders such as xerosis frequently occur in patients with type 1 and type 2 diabetes. Gentle cleansers and moisturizers are...
Read MoreThe Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
April 2023 | Volume 22 | Issue 4 | Original Article | 375 | Copyright © April 2023
Background: Interleukin (IL)-23, a member of the IL-12 family, has emerged as an important cytokine that bridges the innate and adaptive immune systems and plays a critical role ...
Read MoreDrugs in Development for Chronic Spontaneous Urticaria
April 2023 | Volume 22 | Issue 4 | Original Article | 393 | Copyright © April 2023
Media and other results for: "atopic dermatitis"